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lesser magnitude: a decline of 51% in 6-month-old compared to 3-month-
old mice.
In the DMM model OA developed on the medial tibia where the number
of Ihh expressing cells decreased 68% compared to sham operated
individuals. The lateral tibial cartilage did not display a signiﬁcant change
in Ihh expression. In collagenase induced OA, Ihh expression decreased
18% on day 14, 42% on day 21 and 72% on day 42 in medial tibial
cartilage compared to controls. On the lateral side this was 37%, 51%
and 55% respectively.
In spontaneous OA (STR/ort), demonstrating mainly OA development at
the medial tibia, a drastic change in Ihh expression was found with age
and accordingly with OA in this age-related OA model. Whereas there is
still normal Ihh expression at 8 weeks of age, it was almost absent by
the age of 6 months in medial tibial cartilage and was reduced 54% in
lateral tibial cartilage.
Conclusions: In the growth plate Ihh is known to keep chondrocytes in
a pre-hypertrophic state by blocking further (terminal) differentiation. We
found that with age there is a decrease in Ihh expression which is already
found at an age of 6 months in C57Bl/6 mice. In earlier studies we showed
that in normal articular chondrocytes there is high expression of TGF-beta
signaling via the ALK5 receptor, leading to Smad2 phosphorylation. This
pathway is known to block terminal differentiation in chondrocytes. During
ageing and OA, this suppressive pathway of terminal differentiation is
reduced.
In addition, we previously found that the balance between the ALK5
pathway and the alternative TGF-beta pathway via ALK1 leading to
Smad1/5/8 phosphorylation is tilted during OA favoring the ALK1-side.
This Smad1/5/8 pathway is a known stimulator of chondrocyte hyper-
trophy. Thus with age and OA we found a reduction in the block on
terminal differentiation and even a shift towards stimulation of terminal
differentiation. The results of this study, loss of Ihh expression during
ageing and OA, appear to conform the hypothesis that chondrocytes
undergo a shift in phenotype during ageing and OA that make these
cells prone to terminal differentiation-like alterations and ageing cartilage
to OA development.
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Purpose: Transient receptor potential channel vanilloid 4 (TRPV4) is a
calcium permeable cation channel that is gated by a number of factors,
including osmolarity and temperature. Chondrocytes, the cells in articular
cartilage, have been shown to perceive and respond to their osmotic and
mechanical environments; however, the molecular basis of this signal
transduction is not fully understood. The purpose of this study was to
demonstrate the presence and functionality of TRPV4 in porcine articular
cartilage.
Methods: TRPV4 protein expression was examined in porcine chon-
drocytes via Western blotting and immunostaining. TRPV4 mRNA was
measured using RT-PCR. Calcium signaling in response to osmotic
stress, TRPV4 agonist/antagonist, and various calcium signaling modi-
fying agents was measured via ﬂuorescent imaging of calcium-sensitive
dyes. Cell volume change in response to osmotic stress, TRPV4 ag-
onist/antangonist, and the inﬂammatory cytokine, Il-1, were measured
from light microscopy images. Changes in prostaglandin E2 (PGE2),
which is a downstream effect of increased internal calcium and Il-1,
levels in response to osmotic stress and TRPV4 agonist/antagonist were
measured with an immunoassay.
Results: TRPV4 was detected in porcine chondrocytes at the protein
level and mRNA level. Addition of 4a-PDD, a TRPV4 agonist, caused
calcium signaling, which was signiﬁcantly blocked by the addition of
ruthenium red (RR), a TRPV4 antagonist (Fig. 1). Calcium signaling
was also inhibited by removal of extracellular calcium or blocking release
from intracellular stores. Blocking TRPV4 with RR signiﬁcantly modiﬁed
the porcine cellular response to hypo-osmotic stress by decreasing the
percentage of cells responding with a calcium signal. Addition of RR also
signiﬁcantly inhibited the volume recovery in response to hypo-osmotic
stress, and 4a-PDD alone caused a slight volume increase (Fig. 2).
TRPV4 activation was able to prevent the inﬂammatory cytokine Il-1
from inhibiting this volume regulation after exposure to hypo-osmotic
medium (Fig. 2). Hypo-osmotic conditions caused PGE2 release which
was blocked by the addition of RR (Fig. 3).
Fig. 1: Percentage of cells responding to stimuli with increases in intracel-
lular calcium. Asterisks denote experimental groups that are signiﬁcantly
different from control within a given osmolarity (chi-squared test, p< 0.05);
number signs specify bars within the 380 mOsm group that are signiﬁ-
cantly different from 380+4a-PDDm (chi-squared test, p< 0.05). Both the
280 and 480 mOsm controls are signiﬁcantly different from the 380 mOsm
control (chi-squared, p< 0.05).
Fig. 2: Volume recovery (maximum-ﬁnal) after stimulation with different
osmotic and chemical stimuli. Bars are mean (±sem). Bars with different
letters are signiﬁcantly different from one another (ANOVA, p< 0.05).
Fig. 3: Mean (+sem) levels of PGE2 in culture medium after treatment with
different osmolarities and TRPV4 agonists/antagonists. Asterisk indicates
bar is signiﬁcantly different from all others (ANOVA, p< 0.05).
Conclusions: We have shown that TRPV4 is present in articular chon-
drocytes and that chondrocyte response to hypo-osmotic stress is me-
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diated by calcium inﬂux via the TRPV4 channel, which involves both
an inﬂux of extracellular calcium and a release of intracellular calcium
stores. In addition, TRPV4 may be involved in modulating the production
or inﬂuence of pro-inﬂammatory molecules such as PGE2 or Il-1 in hypo-
osmotic conditions. Because of the unique structure of cartilage, mechan-
ical loading is directly coupled to interstitial osmolarity. Thus, in acting
as an osmosensor, TRPV4 may also be acting as a mechanosensor. In
addition to the short-term changes in osmolarity with loading, osmolarity
of cartilage tissue may also change chronically with arthritis.
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Purpose: Prostaglandins (PGs) are phospholipid-derived, hormone-like
molecules that serve as homeostatic bioregulators and immune and in-
ﬂammatory modulators. The rate-limiting enzyme in inducible PG biosyn-
thesis is cyclooxygenase-2 (COX-2). Prostaglandin E2 (PGE2), the ma-
jor COX-2 catalytic product, serves as a feedback regulator of COX-2
(and other pro- and anti-inﬂammatory) gene expression. Exogenous
PGE2 increases primary human synovial ﬁbroblast (HSF) COX-2 mRNA
stability and translation; these effects are dependent on p38 MAPK-
responsive cis-acting adenylate/uridylate-rich elements (AREs) in the
COX-2 3′-untranslated region (3′UTR).
This study’s purpose is to characterize the molecular factors (i.e., ARE
binding proteins, AUBPs) and mechanisms by which PGE2 increases
COX-2 mRNA stability and translation in HSFs.
Methods: Gene reporter studies were conducted to screen three AUBPs
expressed endogenously in HSFs and shown to bind the COX-2 3′UTR
(i.e., AUF-1, HuR, Tristetraprolin (TTP)) for their effect on COX-2 mRNA
stability/translation. HSFs were cotransfected with a luciferase (Luc)-
COX-2 3′UTR reporter construct and one of three expression plasmids
coding for a different AUBP. Luc activity was then quantiﬁed by lumi-
nometry as a measure of both mRNA stability and translation; results
were expressed relative to Luc activity in cells transfected with an empty
AUBP vector (i.e., control). AUBP mRNA and protein expression was an-
alyzed by Northern blotting (NB) and Western blotting (WB), respectively.
Subcellular localization studies were performed using real-time confocal
microscopy of TTP-GFP-transfected HeLa cells; results were conﬁrmed
biochemically by WB.
Results: TTP had the most marked and unambiguous effect on Luc-
COX-2 3′UTR reporter activity in HSFs (55±15% decrease in Luc activ-
ity). HSF TTP mRNA levels were rapidly (20min) and potently (3.5-fold
vs. control) induced by Il-1b, but displayed a short half-life (1−2 h). Neither
Il-1b-induced TTP transcription nor TTP mRNA decay was mediated by
PGE2. Interestingly, three TTP transcripts of 6.0, 4.0 and 2.2 kb were
detected by NB, suggesting the possible existence of additional TTP
isoforms and/or splice variants. In support of this possibility, WB analysis
of HSF TTP revealed the presence of a second TTP immunoreactive
protein (TTP2, ~60 kDa). Exogenous PGE2 almost completely abolished
Il-1b-induced TTP2 protein levels after 17 h of stimulation while minimally
reducing the levels of the known TTP protein (TTP1). To verify if TTP2
is a TTP isoform or splice variant, NB analysis of TTP mRNA was
conducted using nuclear and cytosolic RNA extracts; only the 2.2 kb
TTP transcript was detected in the cytosol, thus indicating that TTP2 is a
post-translationally modiﬁed form of TTP1. Analysis of TTP’s subcellular
localization in HSFs and HeLa cells revealed a predominantly (95%)
cytosolic localization. PGE2 promoted TTP’s nuclear export within 5min;
WB analysis revealed that TTP2 is the shuttling species. The presence
of TTP2 in the nucleus and the fact that it is a zinc-ﬁnger protein led
us to assess its capacity to inﬂuence COX-2 gene transcription. Gene
reporter studies revealed that overexpression of TTP could transactivate
the COX-2 promoter by ~2-fold.
Conclusions: TTP2 is a novel, uncharacterized post-translational variant
of TTP1. Although the exact molecular composition and function of
TTP2 are unknown, it appears that TTP2 exhibits distinct nuclear (i.e.,
transcription) and cytosolic (i.e., mRNA decay/translation) functions with
regards to COX-2 expression. PGE2’s inﬂuence on TTP2’s expression
and subcellular distribution make it a strong candidate effector of PGE2-
mediated transcriptional and post-transcriptional/translational gene regu-
lation.
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Purpose: Racial differences in OA prevalence have been demonstrated
at individual joint sites, but whether there are racial differences in patterns
of multi-joint OA involvement is unknown. The current study was designed
to assess differences in multi-joint rOA phenotypes among AA and White
individuals.
Methods: We conducted a cross-sectional analysis using data from the
Johnston County Osteoarthritis Project (n = 1600, 67% women, 32% AA).
Hand rOA was deﬁned as (1) Kellgren-Lawrence (KL) grade 2 in at least
3 joints, including DIPs, PIPs, or CMC1; (2) at least 2 involved joints in
the same joint group; (3) at least one involved DIP in digits 2−5; and
(4) bilateral distribution. Tibiofemoral (TFJ) or hip joint rOA was deﬁned
as a K/L grade 2; patellofemoral rOA (PFJ) as an osteophyte grade
2; and lumbosacral spine rOA as an osteophyte grade 1 and disc
space narrowing at the same vertebral level. Frequencies were calculated
for all joint sites. Generalized estimating equations (GEE) were used to
investigate racial differences in OA phenotypes simultaneously, adjusting
for correlation among joints of the same individual. Logistic regression
was used to assess multi-joint rOA phenotypes as separate outcomes
(i.e. hand/knee, hand/hip) in a subset of individuals with complete data
for rOA at the hand, TFJ, PFJ, hip, and knee (n = 834), with exact methods
used for outcomes with small cell sizes. Analyses were also adjusted for
age, gender, and BMI.
Results: The mean (SD) age of the sample was 63 (11) years. Overall,
27% of the participants had hand rOA, 33% had TFJ rOA, 49% had PFJ
rOA, 30% had hip rOA, and 49% had rOA of the lumbosacral spine.
In unadjusted analyses by race, Whites more frequently had any hand
rOA (35% vs 11%, p< 0.0001) and rOA of the spine (52% vs 44%,
p = 0.03); AAs more frequently had TFJ rOA (39% vs 30%, p = 0.0003);
and no racial differences were seen for hip or PFJ rOA. Results were
similar in adjusted analyses by race (using GEE) except that there was
no racial association for spine involvement. In unadjusted analyses of
multi-joint rOA phenotypes, compared to those with no rOA at any site
(15% of the subset), AAs had signiﬁcantly decreased frequencies of
isolated hand or PFJ involvement compared to Whites, as well as less
frequent combinations of joints including the hands (hand/TFJ, hand/hip,
hand/TFJ/hip, Table). After adjustment, AAs were less likely to have
any combination of involved joints that included the hands (hand only,
hand/TFJ, hand/hip, or hand/TFJ/hip) compared to Whites. AAs had 50%
increased odds of TFJ and hip involvement together, but this did not reach
statistical signiﬁcance (Table).
Table 1: Unadjusted frequencies and adjusted odds ratios for multi-joint rOA phenotypes, by race
Joint site(s) AA n=231
(%)
White
n=603 (%)
Unadjusted
p value*
Adjusted OR
(95%CI)**
None 50 (22) 78 (13)
Hand only 0 (0) 33 (6) <0.001 0.05 (0−0.32)†
TFJ only 19 (8) 22 (4) 0.409 1.45 (0.64−3.28)
PFJ only 35 (15) 116 (19) 0.004 0.61 (0.35−1.07)
TFJ/PFJ only 10 (4) 10 (2) 0.354 1.59 (0.56−4.48)
Hip only 11 (5) 29 (5) 0.184 0.72 (0.30−1.71)
Hand/TFJ 20 (9) 114 (19) <0.001 0.28 (0.14−0.57)
Hand/hip 4 (2) 23 (4) 0.016 0.34 (0.07−1.25)†
TFJ/hip 58 (25) 77 (14) 0.520 1.52 (0.88−2.61)
Hand/TFJ/hip 24 (10) 101 (17) 0.001 0.40 (0.19−0.85)
*p value for AA vs White, unadjusted frequencies, **aOR for AA vs White, adjusted for age,
gender, and BMI, †by exact logistic model due to small cell count
Conclusions: Multi-joint rOA phenotypes differ by race, with AAs more
likely than Whites to have multiple large joint OA involvement. Deﬁnitions
of generalized OA which emphasize hand involvement, commonly used
in Whites, may not identify AA individuals with multi-joint OA.
